Venetoclax and Bortezomib in Relapsed/Refractory Early T-Cell Precursor Acute Lymphoblastic Leukemia.

ABSTRACT:

SUBMITTER: La Starza R 

PROVIDER: S-EPMC7448796 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature